Examine the Possible Association of Hepatic CYP3A Activity and the Susceptibility to Femur Head Necrosis
NCT00244400 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2006-10-17
Summary
The purpose of the present study was to examine the possible association of hepatic CYP3A activity and the susceptibility to femur head necrosis in patients treated with corticosteroids.
Conditions
- Femur Head Necrosis
Sponsors & Collaborators
-
Osaka City University
lead OTHER
Principal Investigators
-
Yasunori Kaneshiro, M.D. · Department of Orthopedic Surgery, Graduate School of Medicine, Osaka City University
Eligibility
- Min Age
- 14 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2002-11-30
- Completion
- 2006-01-31
Countries
- Japan
Study Locations
More Related Trials
-
Impact of Muscle Insulin Resistance on the Pathogenesis of Non Alcoholic Steatohepatitis
NCT01324414 ·Status: COMPLETED
-
Outcome and Related Factors of Necrotizing Fasciitis of the Limb
NCT00538577 ·Status: COMPLETED
-
Evaluation of 4 MRI Methods (PDFF 3, 6 and 11 Gradient Echoes and Spectroscopy) Compared to the Reference Method (Liver Biopsy) in Quantification of Hepatic Steatosis
NCT03142698 ·Status: UNKNOWN ·Phase: NA
-
Intravenous-Morphine and Glucagon-Usage Enhanced MR Cholangiography
NCT00155376 ·Status: UNKNOWN ·Phase: PHASE4
-
Non Alcoholic Steatohepatitis in Relation to Visceral and Subcutaneous Fat
NCT04240145 ·Status: UNKNOWN
-
Evaluation of Pancreatic Steatosis in Patients With Cancer of Pancreas
NCT02682394 ·Status: UNKNOWN
-
Gadoxetic Acid-enhanced MR Evaluation of Hepatocellular Carcinoma and Dysplastic Nodules in the Cirrhotic Liver
NCT01501240 ·Status: WITHDRAWN
-
Rapid 10-Minute Liver MRI Protocol in Patients With Suspected Hepatocellular Carcinoma
NCT01390194 ·Status: COMPLETED
-
Non-invasive Evaluation of Hepatic Fibrosis in Patients With the Metabolic Syndrome
NCT00399932 ·Status: UNKNOWN
-
Non-Invasive Evaluation of Fibrosis and Steatosis in Chronic Hepatopathy
NCT01246388 ·Status: UNKNOWN
-
MAsS Scan as a Predictor of Morbidity and Mortality in Patients With Liver Disease
NCT05264051 ·Status: RECRUITING
-
Combi-elastography Assessment of HCC Recurrence After Thermal Ablation Multi-center Study
NCT04640363 ·Status: UNKNOWN
-
Precise Evaluation Criteria for Histological Regression of NASH Fibrosis
NCT06364462 ·Status: NOT_YET_RECRUITING
-
CT-guided Localization for Micro Hepatocellular Carcinoma Before Surgical Resection
NCT05433467 ·Status: RECRUITING ·Phase: NA
-
Effects of Coffee on Hepatic Steatosis Induced by a High Fructose Diet
NCT00827450 ·Status: COMPLETED ·Phase: NA
-
Prospective Cohort Study in Patients With NAFLD
NCT00575133 ·Status: RECRUITING
-
A Cross Sectional Study for Determining Prevalence of Sarcopenia and Myosteatosis in Cirrhotic Patients and to Study the Association Between Imaging and Clinical Parameters
NCT05157308 ·Status: UNKNOWN
-
Remote Ischemia Precondition (RIPC) for Hepatic Protection in Patients Undergoing Hepatectomy
NCT02168608 ·Status: UNKNOWN ·Phase: NA
-
Study Visceral Adipose Tissue and Liver Stifness in a Retrospective Cohort of Diabetes Mellitus Patients
NCT04493814 ·Status: UNKNOWN
-
Protocol for Muscle Attenuation Cut-offs in Cirrhosis
NCT06593015 ·Status: COMPLETED
-
Risk of Hepatocellular Carcinoma in Patient With Liver Cirrhosis
NCT03083002 ·Status: UNKNOWN
-
Non-invasive Assessment of Liver Fibrosis in a French Cohort of Pediatric Patients With Type III Glycogen Storage Disease: Current State and Perspectives
NCT07303140 ·Status: RECRUITING
-
The Influence of Autophagy on Fatty Liver
NCT01988441 ·Status: UNKNOWN
-
Risk Prediction of Bleeding in Liver Cirrhosis by Combi-elastography
NCT04640350 ·Status: UNKNOWN
-
Tumor Growth Factors in Hepatocellular Carcinoma
NCT00764140 ·Status: COMPLETED